CBT and medication in depression (Review)

Vasile,Cristian

doi:10.3892/etm.2020.9014

CBT and medication in depression (Review)

Authors:
- Cristian Vasile
View Affiliations

Affiliations: Department of Educational Sciences, Petroleum‑Gas University of Ploiesti, 100680 Ploiesti, Romania
Published online on: July 14, 2020 https://doi.org/10.3892/etm.2020.9014
Pages: 3513-3516
Copyright: © Vasile . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Depression is a serious problem, primarily for the patient, but in‑extenso, for society. The World Health Organization has long signaled an increase in the number of cases of mental health problems globally and, in particular, an increase in the number of people suffering from depression. In the context in which the most effective solutions are sought for the reduction and even remission of depressive symptoms. In the present review literature is analyzed on two current treatment modalities for depression: Cognitive behavioral therapy (CBT) and antidepressive medication (ADM). Both modalities act by the same internal mechanisms, in the same order, but studies found also differences between the ADM and CBT effects depending on early traumatic experiences of the patients, cognitive and genetic variables, other epigenetic factors and patient's history. A literature review is presented, which systematically collects actual data and synthesizes previous research findings in the field of depression treatment using ADM and CBT.

View Figures

View References

1	DeRubeis RJ and Strunk DR: The Oxford Handbook of Mood Disorders. In: Oxford Library of Psychology. 1st edition. Oxford University Press, New York, NY, 2017.
2	World Health Organization: Depression and other common mental disorders. Global Health Estimates, Geneva, 2017.
3	Trifu S, Mihailescu R, Stegarescu S and Ion I: Evolutional perspective over some key-aspects in psychiatry. Theoretical and Applied in Psychology (SICAP23): Psychology and ongoing development. Editografica, Bologna, p179, 2016.
4	James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al: GBD 2017 Disease and Injury Incidence and Prevalence Collaborators: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392:1789–1858. 2018.PubMed/NCBI View Article : Google Scholar
5	DeRubeis RJ, Siegle GJ and Hollon SD: Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms. Nat Rev Neurosci. 9:788–796. 2008.PubMed/NCBI View Article : Google Scholar
6	Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ and Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 48:851–855. 1991.PubMed/NCBI View Article : Google Scholar
7	Trifu S: Dissociative identity disorder Psychotic functioning and impairment of growing-up processes. J Educ Sci Psychol. 9:102–108. 2019.
8	Siegle GJ, Thompson W, Carter CS, Steinhauer SR and Thase ME: Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: Related and independent features. Biol Psychiatry. 61:198–209. 2007.PubMed/NCBI View Article : Google Scholar
9	Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, et al: Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry. 156:675–682. 1999.PubMed/NCBI View Article : Google Scholar
10	Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH and Sumida RM: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:243–250. 1989.PubMed/NCBI View Article : Google Scholar
11	O'Donnell S, Syoufi M, Jones W, Bennett K and Pelletier L: Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders. Health Promotion and Chronic Disease Prevention in Canada. Research. Policy Pract. 37:160–171. 2017.PubMed/NCBI View Article : Google Scholar
12	Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB and Mayberg HS: Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry. 174:533–545. 2017.PubMed/NCBI View Article : Google Scholar
13	Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J and Mortensen EL: The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: Pragmatic randomised controlled clinical trial. Br J Psychiatry. 208:252–259. 2016.PubMed/NCBI View Article : Google Scholar
14	Huijbers MJ, Spinhoven P, Spijker J, Ruhé HG, van Schaik DJ, van Oppen P, Nolen WA, Ormel J, Kuyken W, van der Wilt GJ, et al: Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: Randomised controlled non-inferiority trial. Br J Psychiatry. 208:366–373. 2016.PubMed/NCBI View Article : Google Scholar
15	Beshai S, Watson LM, Meadows TJS and Soucy JN: Perceptions of cognitive-behavioral therapy and antidepressant medication for depression after brief psychoeducation: Examining shifts in attitudes. Behav Ther. 50:851–863. 2019.PubMed/NCBI View Article : Google Scholar
16	Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, et al: Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 74:658–670. 2006.PubMed/NCBI View Article : Google Scholar
17	Sinniah A, Oei TP, Maniam T and Subramaniam P: Positive effects of individual cognitive behavior therapy for patients with unipolar mood disorders with suicidal ideation in Malaysia: A randomised controlled trial. Psychiatry Res. 254:179–189. 2017.PubMed/NCBI View Article : Google Scholar
18	Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP Jr, Weiss PM, Dunner DL, et al: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA. 100:14293–14296. 2003.PubMed/NCBI View Article : Google Scholar
19	Trifu S and Trifu AD: Receptor profiles of atypical antipsychotic molecules U.P.B. Sci Bull. 82:113–128. 2020.